Bio-Rad's equity position in a German pharma company is an asset many investors may not realize.
Compare BIO Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Bio-Rad Laboratories
They are coming off strong quarters, yet appear to be underpriced based on their fundamentals. Is now a good time to buy?
BIO earnings call for the period ending June 30, 2021.
BIO earnings call for the period ending March 31, 2021.
BIO earnings call for the period ending December 31, 2020.
BIO earnings call for the period ending September 30, 2020.
Savvy investors should consider adding these stocks to their portfolio to enhance its performance and diversity.
BIO, BIO.B earnings call for the period ending June 30, 2020.
BIO, BIO.B earnings call for the period ending March 31, 2020.
There's a strong case to be made for both companies, but which one is a better investment?